Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle

Clinical trial NCT07421024 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07421024
Sponsor: Morten Hostrup, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2026-02-20
Primary completion: 2026-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.